Mineralys Therapeutics, Inc. MLYS
14.01 USD -0.47 (-3.25%)
As ofNov 18, 2026, 11:49 AM EST
13.85 Day range 14.48
13.85 52-week range 45.00
- YTD
- -61.39%
- 1 year
- -67.71%
News
defenseworld.net 87,400 Shares of Mineralys Therapeutics, Inc. $MLYS Acquired by ACT Capital Partners L.P. ACT Capital Partners L.P. purchased a new stake in shares of Mineralys Therapeutics, Inc. (NASDAQ: MLYS) during the undefined quarter, according to its most recent filing with the SEC. The…
benzinga.com Mineralys Therapeutics Q3 2026 Earnings Call Transcript Mineralys Therapeutics (NASDAQ:MLYS) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…benzinga.com Mineralys Therapeutics Announces Phase 2 Explore-CKD Trial Met Its Primary Endpoint; Publishes Full Results In The Journal 'Kidney International' The Explore-CKD trial evaluated the efficacy and safety of lorundrostat, an aldosterone synthase inhibitor, added to guideline-directed background therapy in 59 participants with uncontrolled…
